Neuroprotective effects of the drug GVT (monosodium luminol) are mediated by the stabilization of Nrf2 in astrocytes

Neurochemistry International

Volumn 56, Issue 6-7, 2010, Pages 780-788

  Reddy, Pichili Vijaya Bhaskar ^a   Lungu, Gina ^b   Kuang, Xianghong ^a   Stoica, George ^b   Wong, Paul K Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

GVT; HAD; Moloney murine leukemia virus ts1; Nrf2; Oxidative stress

Indexed keywords

MESSENGER RNA; MONOSODIUM LUMINOL; NEUROPROTECTIVE AGENT; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; DRUG MECHANISM; GENE EXPRESSION; HIV ASSOCIATED DEMENTIA; IMMUNOHISTOCHEMISTRY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; UPREGULATION; VIRUS MUTANT;

ANIMALS; ASTROCYTES; BRAIN STEM; CELL LINE, TRANSFORMED; CYSTEINE PROTEINASE INHIBITORS; LEUPEPTINS; LUMINOL; MICE; MOLONEY MURINE LEUKEMIA VIRUS; MUTATION; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

HUMAN IMMUNODEFICIENCY VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MUS;

EID: 77952262829     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.02.017     Document Type: Article

References (77)

1. Betteridge D.J. What is oxidative stress?. Metabolism 2000, 49:3-8.
2. Calkins M.J., Jakel R.J., Johnson D.A., Chan K., Kan Y.W., Johnson J.A. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:244-249.
3. Calkins M.J., Johnson D.A., Townsend J.A., Vargas M.R., Dowell J.A., Williamson T.P., Kraft A.D., Lee J.M., Li J., Johnson J.A. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2008.
4. Cerimele F., Battle T., Lynch R., Frank D.A., Murad E., Cohen C., Macaron N., Sixbey J., Smith K., Watnick R.S., Eliopoulos A., Shehata B., Arbiser J.L. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:175-179.
5. Chen P., Peng C., Luff J., Spring K., Watters D., Bottle S., Furuya S., Lavin M.F. Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice. J. Neurosci. 2003, 23:11453-11460.
6. Cho H.Y., Imani F., Miller-DeGraff L., Walters D., Melendi G.A., Yamamoto M., Polack F.P., Kleeberger S.R. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 2009, 179:138-150.
7. Clark S., Duggan J., Chakraborty J. Ts1 and LP-BM5: a comparison of two murine retrovirus models for HIV. Viral Immunol. 2001, 14:95-109.
8. Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15091-15096.
9. Ghadge G.D., Lee J.P., Bindokas V.P., Jordan J., Ma L., Miller R.J., Roos R.P. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 1997, 17:8756-8766.
10. Gonzalez-Scarano F., Nathanson N., Wong P. Retroviruses and the Nervous System 1995, Plenum Press, New York.
11. Grinberg L., Fibach E., Amer J., Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic. Biol. Med. 2005, 38:136-145.
12. Gross S., Gammon S.T., Moss B.L., Rauch D., Harding J., Heinecke J.W., Ratner L., Piwnica-Worms D. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 2009, 15:455-461.
13. He X., Chen M.G., Ma Q. Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem. Res. Toxicol. 2008, 21:1375-1383.
14. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
15. Jiang Y., Scofield V.L., Yan M., Qiang W., Liu N., Reid A.J., Lynn W.S., Wong P.K. Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium alpha-luminol (Galavit). J. Virol. 2006, 80:4557-4569.
16. Johnson D.A., Andrews G.K., Xu W., Johnson J.A. Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice. J. Neurochem. 2002, 81:1233-1241.
17. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., Chen P.C. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:61-69.
18. Kanninen K., Heikkinen R., Malm T., Rolova T., Kuhmonen S., Leinonen H., Yla-Herttuala S., Tanila H., Levonen A.L., Koistinaho M., Koistinaho J. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:16505-16510.
19. Kanninen K., Malm T.M., Jyrkkanen H.K., Goldsteins G., Keksa-Goldsteine V., Tanila H., Yamamoto M., Yla-Herttuala S., Levonen A.L., Koistinaho J. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol. Cell. Neurosci. 2008, 39:302-313.
20. Kim H.T., Qiang W., Wong P.K., Stoica G. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation. J. Neurovirol. 2001, 7:466-475.
21. Kim H.T., Tasca S., Qiang W., Wong P.K., Stoica G. Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab. Invest. 2002, 82:693-702.
22. Kim H.T., Waters K., Stoica G., Qiang W., Liu N., Scofield V.L., Wong P.K. Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy. Lab. Invest. 2004, 84:816-827.
23. Kim J., Cha Y.N., Surh Y.J. A protective role of nuclear erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat. Res. 2009.
24. Kim J., Wong P.K. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cells 2009, 27:1987-1998.
25. Kim J., Wong P.K. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J. Biol. Chem. 2009, 284:14396-14404.
26. Kraft A.D., Johnson D.A., Johnson J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 2004, 24:1101-1112.
27. Kuang X., Scofield V.L., Yan M., Stoica G., Liu N., Wong P.K. Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res. 2009, 1286:174-184.
28. Kumar S., Kalita J., Saxena V., Khan M.Y., Khanna V.K., Sharma S., Dhole T.N., Misra U.K. Some observations on the tropism of Japanese encephalitis virus in rat brain. Brain Res. 2009, 1268:135-141.
29. Kumar S., Misra U.K., Kalita J., Khanna V.K., Khan M.Y. Imbalance in oxidant/antioxidant system in different brain regions of rat after the infection of Japanese encephalitis virus. Neurochem. Int. 2009, 55:648-654.
30. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 2003, 278:12029-12038.
31. Lee J.M., Li J., Johnson D.A., Stein T.D., Kraft A.D., Calkins M.J., Jakel R.J., Johnson J.A. Nrf2, a multi-organ protector?. FASEB J. 2005, 19:1061-1066.
32. Lee Y., Chong M.J., McKinnon P.J. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J. Neurosci. 2001, 21:6687-6693.
33. Lewerenz J., Albrecht P., Tien M.L., Henke N., Karumbayaram S., Kornblum H., Wiedau-Pazos M., Schubert D., Maher P., Methner A. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. N. Neurochem. 2009, 111:332-343.
34. Li J., Calkins M.J., Johnson D.A., Johnson J.A. Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods Mol. Biol. 2007, 399:67-78.
35. Li J., Johnson D., Calkins M., Wright L., Svendsen C., Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 2005, 83:313-328.
36. Lin Y.C., Chow C.W., Yuen P.H., Wong P.K. Establishment and characterization of conditionally immortalized astrocytes to study their interaction with ts1, a neuropathogenic mutant of Moloney murine leukemia virus. J. Neurovirol. 1997, 3:28-37.
37. Liu N., Kuang X., Kim H.T., Stoica G., Qiang W., Scofield V.L., Wong P.K. Possible involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in MoMuLV-ts1-induced apoptosis in astrocytes. J. Neurovirol. 2004, 10:189-198.
38. Liu N., Scofield V.L., Qiang W., Yan M., Kuang X., Wong P.K. Interaction between endoplasmic reticulum stress and caspase 8 activation in retrovirus MoMuLV-ts1-infected astrocytes. Virology 2006, 348:398-405.
39. Liu N., Stoica G., Yan M., Scofield V.L., Qiang W., Lynn W.S., Wong P.K. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab. Invest. 2005, 85:1471-1480.
40. Lynn W.S., Wong P.K. Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death?. FASEB J. 1995, 9:1147-1156.
41. Lynn W.S., Wong P.K. Neuroimmunopathogenesis of ts1 MoMuLV viral infection. Neuroimmunomodulation 1998, 5:248-260.
42. Maksimovic I.D., Jovanovic M.D., Colic M., Mihajlovic R., Micic D., Selakovic V., Ninkovic M., Malicevic Z., Rusic-Stojiljkovic M., Jovicic A. Oxidative damage and metabolic dysfunction in experimental Huntington's disease: selective vulnerability of the striatum and hippocampus. Vojnosanit. Pregl. 2001, 58:237-242.
43. Mishra M.K., Ghosh D., Duseja R., Basu A. Antioxidant potential of minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem. Int. 2009, 54:464-470.
44. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9926-9930.
45. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 2001, 24:411-416.
46. Offen D., Gilgun-Sherki Y., Barhum Y., Benhar M., Grinberg L., Reich R., Melamed E., Atlas D. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 2004, 89:1241-1251.
47. Polidori M.C., Mecocci P., Browne S.E., Senin U., Beal M.F. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neurosci. Lett. 1999, 272:53-56.
48. Qiang W., Cahill J.M., Liu J., Kuang X., Liu N., Scofield V.L., Voorhees J.R., Reid A.J., Yan M., Lynn W.S., Wong P.K. Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J. Virol. 2004, 78:11926-11938.
49. Qiang W., Kuang X., Liu J., Liu N., Scofield V., Stoica G., Lynn W.S., Wong P.K.Y. Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J. Virol. 2006, 80:3273-3284.
50. Reddy N.M., Kleeberger S.R., Kensler T.W., Yamamoto M., Hassoun P.M., Reddy S.P. Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J. Immunol. 2009, 182:7264-7271.
51. Reddy N.M., Suryanarayana V., Kalvakolanu D.V., Yamamoto M., Kensler T.W., Hassoun P.M., Kleeberger S.R., Reddy S.P. Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J. Immunol. 2009, 183:4601-4608.
52. Reddy P.V., Murthy Ch R., Reddanna P. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci. Lett. 2004, 368:15-20.
53. Ronaldson P.T., Bendayan R. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J. Neurochem. 2008, 106:1298-1313.
54. Rushmore T.H., Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002, 3:481-490.
55. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 1990, 265:14648-14653.
56. Sacktor N., Cutler H.N., Tamara R., Turchan A., Pardo J., Vargas C., Nath D.A. Novel markers of oxidative stress in actively progressive HIV dementia. J. Neuroimmunol. 2004, 157:176-184.
57. Sanders J.M., Chen L.J., Burka L.T., Matthews H.B. Metabolism and disposition of luminol in the rat. Xenobiotica 2000, 30:263-272.
58. Scofield V.L., Yan M., Kuang X., Kim S.J., Crunk D., Wong P.K. The drug monosodium luminol (GVT) preserves thymic epithelial cell cytoarchitecture and allows thymocyte survival in mice infected with the T cell-tropic, cytopathic retrovirus ts1. Immunol. Lett. 2009, 122:159-169.
59. Scofield V.L., Yan M., Kuang X., Kim S.J., Wong P.K. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Immunol. Lett. 2009, 122:150-158.
60. Shih A.Y., Johnson D.A., Wong G., Kraft A.D., Jiang L., Erb H., Johnson J.A., Murphy T.H. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 2003, 23:3394-3406.
61. Shikova E., Lin Y.C., Saha K., Brooks B.R., Wong P.K. Correlation of specific virus-astrocyte interactions and cytopathic effects induced by ts1, a neurovirulent mutant of Moloney murine leukemia virus. J. Virol. 1993, 67:1137-1147.
62. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10540-10543.
63. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature 1996, 382:120-121.
64. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:1398-1400.
65. Steiner J., Haughey N., Li W., Venkatesan A., Anderson C., Reid R., Malpica T., Pocernich C., Butterfield D.A., Nath A. Oxidative stress and therapeutic approaches in HIV dementia. Antioxid. Redox Signal. 2006, 8:2089-2100.
66. Stoica G., Floyd E., Illanes O., Wong P.K. Temporal lymphoreticular changes caused by ts1, a paralytogenic mutant of Moloney murine leukemia virus TB. Lab. Invest. 1992, 66:427-436.
67. Stoica G., Illanes O., Tasca S.I., Wong P.K. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB. Lab. Invest. 1993, 69:724-735.
68. Stoica G., Tasca S.I., Wong P.K. Motor neuronal loss and neurofilament-ubiquitin alteration in MoMuLV-ts1 encephalopathy. Acta Neuropathol. 2000, 99:238-244.
69. Szurek P.F., Floyd E., Yuen P.H., Wong P.K. Site-directed mutagenesis of the codon for Ile-25 in gPr80env alters the neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J. Virol. 1990, 64:5241-5249.
70. Szurek P.F., Yuen P.H., Ball J.K., Wong P.K. A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J. Virol. 1990, 64:467-475.
71. Valyi-Nagy T., Dermody T.S. Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histol. Histopathol. 2005, 20:957-967.
72. Vargas M.R., Johnson J.A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert. Rev. Mol. Med. 2009, 11:e17.
73. Warabi E., Takabe W., Minami T., Inoue K., Itoh K., Yamamoto M., Ishii T., Kodama T., Noguchi N. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic. Biol. Med. 2007, 42:260-269.
74. Wong P.K. Moloney murine leukemia virus temperature-sensitive mutants: a model for retrovirus-induced neurologic disorders. Curr. Top. Microbiol. Immunol. 1990, 160:29-60.
75. Wong P.K., Floyd E., Szurek P.F. High susceptibility of FVB/N mice to the paralytic disease induced by ts1, a mutant of Moloney murine leukemia virus TB. Virology 1991, 180:365-371.
76. Wong P.K., Knupp C., Yuen P.H., Soong M.M., Zachary J.F., Tompkins W.A. ts1, a Paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture. J. Virol. 1985, 55:760-767.
77. Wong P.K., Prasad G., Hansen J., Yuen P.H. ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice. Virology 1989, 170:450-459.